Hyperthermia for prostate cancer: A review

Prostate Journal

Volumn 1, Issue 4, 1999, Pages 174-178

  Hurwitz, Mark D ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 28944436543     PISSN: 10955100     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1411.1999.14001.x     Document Type: Review

References (41)

1. Overgaard J. (1989) The current and potential role of hyperthermia in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 16: 535-549.
2. Perez CA, Pajak T, Emami B, et al. (1991) Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors: Final report by the Radiation Therapy Oncology Group. Am. J. Clin. Oncol. 14: 133-141.
3. Hanks GE, Hanlon AL, Schultheiss TE, et al. (1998) Dose escalation with 3D conformal treatment: Five year outcomes, treatment optimization, and future directions. Int. J. Radiat. Oncol. Biol. Phys. 41: 501-510
4. Zelefsky MJ, Leibel SA, Gaudin PB, et al. (1998) Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 41: 491-500.
5. Astrahan MA, Sapoznick MD, Cohen D, et al. (1989) Microwave applicator for transurethral hyperthermia of benign prostatic hyperplasia. Int. J. Hyperthermia. 5: 283.
6. Stawarz B., Szmigielski S, Ogrocnik J, et al. (1991) A comparison of transurethral and transrectal microwave hyperthermia in poor surgical risk benign prostatic hyperplasia patients. J. Urol. 146: 353.
7. Petrovich Z, Ameye F, Baert L, et al. (1993) New trends in the treatment of benign prostatic hyperplasia and carcinoma of the prostate. Am. J. Clin. Oncol. 16: 187.
8. Hahn GM. (1979) Potential for therapy of drugs and hyperthermia. Cancer Res. 39: 2264.
9. Marmor J. (1979) Reactions of hyperthermia and chemotherapy in animals. Cancer Res. 39: 2269.
10. Adams GE, Stratford IJ, Rajaratnun S. (1982) Interaction of the cytotoxic and sensitizing effect of electron-affinic drugs and hyperthermia. Natl. Cancer Inst. Monogr. 61: 27.
11. Roizen-Towle L, Hall EJ, Capuano L. (1982) Interaction of hyperthermia and cytotoxic agents. J. Natl. Cancer Inst. Monogr. 61: 149-151
12. Herman TS, Sweets CC, White DM, et al. (1982) Effects of heating on lethality due to hyperthermia and selected chemotherapeutic drugs. J. Natl. Cancer Inst. 68: 487.
13. Kano E. (1985) Hyperthermia and drugs. In: Overgaard J (ed). Hyperthermia Oncology. Taylor and Francis, London, pp 277-282.
14. Herman TS, Teicher BA. (1988) Sequencing of trimodality therapy (cis-Diamminedichloroplatinum (II)/hyperthermia/radiation) as determined by tumor regrowth delay and tumor cell survival in the FSaIIC fibrosarcoma. Cancer Res. 48: 2693.
15. Westra A, Dewey WC. (1971) Variation in sensitivity to heat shock during the cell cycle of Chinese Hamster cells in vitro. Int. J. Radiat. Biol. 19: 467-477.
16. Dewey, WC, Hopwood LE, Sapareto SA, et al. (1977) Cellular responses to combinations of hyperthermia and radiation. Radiology 123: 463.
17. Emami B, Song CW. (1984) Physiological mechanisms in hyperthermia: A review. Int. J. Radiat. Oncol. Biol. Phys. 10: 289.
18. Gerweck LE, Steele, EL. (1988) Metabolic indices for hyperthermia in cancer therapy. In: Paliwal BR, Jelzel FW, Dewhirst MW (eds). Biological, Physical, and Clinical Aspects of Hyperthermia. Medical Physics Monograph No. 16. New York, American Association of Physicists in Medicine, p 2.
19. Harmon BV, Takano YS, Winterford CM, et al. (1991) The role of apoptosis in theresponse of cells and tumours to mild hyperthermia. Int. J. Radiat. Biol. 59: 489-501.
20. Fuller KJ, Issels RD, Slosman DO, et al. (1994) Cancer and the heat shock response. Eur. J. Cancer 30A(12): 1884-1891.
21. Sevadio C, Leib Z. (1991) Local hyperthermia for prostate cancer. Urology 38: 307-309.
22. Stawarz B, Zielinski H, Szmigielski S, et al. (1993) Transrectal hyperthermia as palliative treatment for advanced adenocarcinoma of prostate and studies of cell-mediated immunity. Urology 41: 548-553.
23. Oleson JR, Samulski TV, Leopold KA, et al. (1993) Sensitivity of hyperthermia treatment outcomes to temperature and time: Implications for thermal goals of treatment. Int. J. Radiat. Oncol. Biol. Phys. 25: 289.
24. Anscher MS, Samulski TV, Leopold KA, et al. (1992) Phase I/II study of external radio frequency phased array hyperthermia and external beam radiotherapy in the treatment of prostate cancer: Technique and results of intraprostatic temperature measurements. Int. J. Radiat. Oncol. Biol. Phys. 24: 489-495.
25. Anscher MS, Samulski TV, Dodge R, et al. (1997) Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 37: 1059-1065.
26. Mendecki J, Friedenthal E, Botstein C, et al. (1980) Microwave applicators for localized hyperthermia treatment of cancer of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 6: 1583-1588.
27. Yerushalmi A, Servadio C, Leib Z, et al. (1982) Local hyperthermia for treatment of carcinoma of the prostate: A preliminary report. Prostate 3: 623-630.
28. Montorsi F, Guazzoni G, Colombo R, et al. (1992) Transrectal microwave hyperthermia for benign prostatic hyperplasia: long-term clinical, pathological and ultrastructural patterns. J. Urol. 148(2 part 1):342-345.
29. Zerbib M, Conquy S, Steg A, et al. (1992) Localized transrectal hyperthermia in the treatment of obstructive manifestations of prostatic adenoma: Review of the literature and personal experience. J. Urol. 98: 89-92.
30. Hynynen K. (1995) Ultrasound heating technology. In: Seegenschmiedt MH, Fessenden P, Vernon CC (eds). Thermo-Radiotherapy and Thermo-Chemotherapy. Springer-Verlag, Berlin, Vol. 1, p 253.
31. Fosmire H, Hynynen K., Drach GW, et al. (1993) Feasibility and toxicity of transrectal ultrasound hyperthermia in the treatment of locally advanced adenocarcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 26: 253-259.
32. Hurwitz MD, Kaplan ID, Svensson GK, et al. (1999) Preliminary report of feasibility and patient tolerance of a novel transrectal ultrasound hyperthermia system for the treatment of prostate cancer. Proceedings of the 18th Annual Meeting of the North American Hyperthermia Society, Philadelphia, PA, April 8-10.
33. Prionas S, Kapp D, Goffinet D, et al. (1994) Thermometry of interstitial hyperthermia given as an adjuvant to brachytherapy for the treatment of carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 28: 151-162.
34. Brezovich IA, Meredith RF. (1989) Practical aspects of ferromagnetic thermoseed hyperthermia. Radiol. Clin. North Am. 27: 589.
35. Emami B, Myerson RJ, Scott C, et al. (1991) Phase I/II study, combination of radiotherapy and hyperthermia in patients with deep-seated malignant tumors: report of a pilot study by the Radiation Therapy Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 20: 73-79.
36. Emami B, Scott C, Perez CA, et al. (1996) Phase III study of interstitial thermoradiotherapy compared with radiotherapy alone in the treatment of recurrent or persistant human tumors: A prospective controlled randomized study by the Radiation Therapy Group. Int. J. Radiat. Oncol. Biol. Phys. 34: 1097-1104.
37. Myerson RJ, Scott CB, Emami B, et al. (1996) A phase I/II study to evaluate radiation therapy and hyperthermia for deep-seated tumors: A report of RTOG 89-08. Int. J. Hyperthermia 12: 449-459.
38. Samulski TV, MacFall J, Zhang Y, et al. (1992) Non-invasive thermometry using magnetic resonance diffusion imaging: Potential for application in hyperthermic oncology. Int. J. Hyperthermia 8: 819.
39. DePorter J, DeWagter C, Deene Y, et al. (1995) Non-invasive MRI thermometry with the proton magnetic resonance frequency (PRF) method: In vivo results in human muscle. Magn. Reson. Med. 33: 74.
40. Gelet A, Chapelon JY, Bouvier R, et al. (1999) Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: Preliminary results. J. Urol. 161: 156-162.
41. Beerlage HP, van Leenders GJ, Oosterof GO, et al. (1999) High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: Results of a prospective study. Prostate 39: 41-46.